These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8174238)

  • 1. Glycated protein update: implications of recent studies, including the diabetes control and complications trial.
    Benjamin RJ; Sacks DB
    Clin Chem; 1994 May; 40(5):683-7. PubMed ID: 8174238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?
    Konig M; Lamos EM; Stein SA; Davis SN
    Curr Diabetes Rev; 2013 Sep; 9(5):371-81. PubMed ID: 23865412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening, diagnosis and management of diabetes mellitus and diabetic complications].
    Lehmann R; Spinas GA
    Ther Umsch; 2000 Jan; 57(1):12-21. PubMed ID: 10667077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of metabolic control in diabetes mellitus].
    Magnusson K; Sawicki PT
    Versicherungsmedizin; 1997 Feb; 49(1):4-7. PubMed ID: 9133032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
    Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
    J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14. Diabetes Care in the Hospital:
    American Diabetes Association
    Diabetes Care; 2018 Jan; 41(Suppl 1):S144-S151. PubMed ID: 29222385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-monitoring of blood glucose in treatment of type 2 diabetes.
    Szymborska-Kajanek A; Psurek A; Hese R; Strojek K
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S49-52. PubMed ID: 20115932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive glycemic control and cardiovascular disease: an update.
    Brown A; Reynolds LR; Bruemmer D
    Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose control guidelines: current concepts.
    Barranco JG
    Clin Nutr; 1998 Sep; 17 Suppl 2():7-17. PubMed ID: 10205355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
    Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?
    Nathan DM
    Diabetes Care; 1995 Feb; 18(2):251-7. PubMed ID: 7729307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.